Perkins Coie Trust CO Astrazeneca PLC Transaction History

Perkins Coie Trust CO

$421 Million
Q1 2025

A detailed history of Perkins Coie Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Perkins Coie Trust CO holds 6 shares of AZN stock, worth $419. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$419

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 Apr 11, 2025	BUY	$65.37 - $77.96 $392 - $467	6 New	6 $0
Q3 2023 Oct 11, 2023	BUY	$64.85 - $71.7 $2,529 - $2,796	39 New	39 $2,000

Others Institutions Holding AZN

# of Institutions

1,428

Shares Held

504M

Call Options Held

10M

Put Options Held

3.14M

Price T Rowe Associates Inc Baltimore, MD

57.1M
Shares

$3.99 Billion
0.52% of portfolio
Primecap Management CO Pasadena, CA

40.7M
Shares

$2.84 Billion
2.53% of portfolio
Wellington Management Group LLP Boston, MA

35.6M
Shares

$2.49 Billion
0.52% of portfolio
Bank Of America Corp Charlotte, NC

31.8M
Shares

$2.22 Billion
0.19% of portfolio
Capital International Investors Los Angeles, CA

31.3M
Shares

$2.19 Billion
0.47% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $216B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Coie Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Coie Trust CO with notifications on news.

Account